title: Marker lesion experiments in bladder cancer--what have we learned?
authors.affiliation: Department of Urology, Hadassah Hebrew University Hospital, Jerusalem, Israel. ogofrit@gmail.com
authors.forename: Ofer N
authors.initials: ON
authors.lastname: Gofrit
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Zorn
authors.forename: Sergey
authors.initials: S
authors.lastname: Shikanov
authors.forename: Gary D
authors.initials: GD
authors.lastname: Steinberg
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017115:Catheter Ablation; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents